Cargando…

Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium

BACKGROUND: The risk of heart failure among diabetic individuals is high, even under tight glycemic control. The correlates and mediators of heart failure risk in individuals with diabetes need more elucidation in large population-based cohorts with long follow-up times and a wide panel of biologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuori, Matti A., Reinikainen, Jaakko, Söderberg, Stefan, Bergdahl, Ellinor, Jousilahti, Pekka, Tunstall-Pedoe, Hugh, Zeller, Tanja, Westermann, Dirk, Sans, Susana, Linneberg, Allan, Iacoviello, Licia, Costanzo, Simona, Salomaa, Veikko, Blankenberg, Stefan, Kuulasmaa, Kari, Niiranen, Teemu J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479921/ https://www.ncbi.nlm.nih.gov/pubmed/34583686 http://dx.doi.org/10.1186/s12933-021-01378-4

Ejemplares similares

Influence of geographical latitude on vitamin D status: cross-sectional results from the BiomarCaRE consortium
por: Oskarsson, Viktor, et al.
Publicado: (2022)

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population‐based cohorts: the BiomarCaRE project
por: Rehm, Martin, et al.
Publicado: (2021)

Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project
por: Camen, Stephan, et al.
Publicado: (2020)

Diabetes and heart failure associations in women and men: Results from the MORGAM consortium
por: Chadalavada, Sucharitha, et al.
Publicado: (2023)

Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project
por: Rothenbacher, Dietrich, et al.
Publicado: (2020)

Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium
por: Waldeyer, Christoph, et al.
Publicado: (2017)

BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries
por: Zeller, Tanja, et al.
Publicado: (2014)

Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
por: Blankenberg, Stefan, et al.
Publicado: (2016)

Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium
por: Sujana, Chaterina, et al.
Publicado: (2022)

Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium
por: Morseth, Bente, et al.
Publicado: (2021)

Association of glycated hemoglobin A(1c) levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
por: Sinning, Christoph, et al.
Publicado: (2021)

Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project
por: Vishram, Julie K. K., et al.
Publicado: (2014)

Correction: Impact of Age and Gender on the Prevalence and Prognostic Importance of the Metabolic Syndrome and Its Components in Europeans. The MORGAM Prospective Cohort Project
por: Vishram, Julie K. K., et al.
Publicado: (2015)

Roles of allostatic load, lifestyle and clinical risk factors in mediating the association between education and coronary heart disease risk in Europe
por: Hicks, Blánaid, et al.
Publicado: (2021)

Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project
por: Rosberg, Victoria, et al.
Publicado: (2022)

Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
por: Schrage, Benedikt, et al.
Publicado: (2020)

Case-cohort design in practice – experiences from the MORGAM Project
por: Kulathinal, Sangita, et al.
Publicado: (2007)

Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation
por: Camen, Stephan, et al.
Publicado: (2022)

Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts
por: Hughes, Maria F., et al.
Publicado: (2012)

Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020)

Lack of association between polymorphisms of the IL18R1 and IL18RAP genes and cardiovascular risk: the MORGAM Project
por: Grisoni, Marie-Lise, et al.
Publicado: (2009)

24-h urinary sodium excretion and the risk of adverse outcomes
por: Vuori, Matti A., et al.
Publicado: (2020)

Predictive value of low testosterone concentrations regarding coronary heart disease and mortality in men and women – evidence from the FINRISK97 study
por: Zeller, T., et al.
Publicado: (2019)

Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods
por: Toprak, Betül, et al.
Publicado: (2023)

Combined Influence of Waist and Hip Circumference on Risk of Death in a Large Cohort of European and Australian Adults
por: Cameron, Adrian J., et al.
Publicado: (2020)

Low testosterone concentrations and prediction of future heart failure in men and in women: evidence from the large FINRISK97 study
por: Schäfer, Sarina, et al.
Publicado: (2021)

Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes
por: Salomaa, Veikko, et al.
Publicado: (2010)

Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes
por: Csengeri, Dora, et al.
Publicado: (2021)

Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium
por: Brunner, Fabian J, et al.
Publicado: (2019)

Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
por: Börschel, Christin S, et al.
Publicado: (2021)

Association of iron deficiency with incident cardiovascular diseases and mortality in the general population
por: Schrage, Benedikt, et al.
Publicado: (2021)

Prime mover or fellow traveller: 25-hydroxy vitamin D’s seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)
por: Tunstall-Pedoe, Hugh, et al.
Publicado: (2015)

Coronary Risk Factors and Their Assessment
por: Tunstall-Pedoe, Hugh
Publicado: (1993)

Testosterone Levels and Type 2 Diabetes—No Correlation with Age, Differential Predictive Value in Men and Women
por: Karakas, Mahir, et al.
Publicado: (2018)

Inflammatory proteomics profiling for prediction of incident atrial fibrillation
por: Börschel, Christin S, et al.
Publicado: (2023)

Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS
por: Boersma, Eric, et al.
Publicado: (2019)

An arrhythmogenic metabolite in atrial fibrillation
por: Krause, Julia, et al.
Publicado: (2023)

Graphics and statistics for cardiology: clinical prediction rules
por: Woodward, Mark, et al.
Publicado: (2017)

Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease
por: Fluschnik, Nina, et al.
Publicado: (2018)

Comparison of Three Troponins as Predictors of Future Cardiovascular Events – Prospective Results from the FINRISK and BiomaCaRE Studies
por: Neumann, Johannes Tobias, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l5atd8vk10nv0h4o1qmokp7217